ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$88.92
*  
0.93
1.06%
Get ALNY Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
5 Best Biotech Stocks to Buy Now
10/21/2014 10:33:02 AM - InvestorPlace Media


Moving Average Crossover Alert: Alnylam Pharmaceuticals (ALNY) - Tale of the Tape
10/16/2014 8:24:20 AM - Zacks.com


Alnylam Reveals Positive Data from its Pipeline Candidates - Analyst Blog
10/15/2014 4:30:00 PM - Zacks.com


Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
10/14/2014 4:45:00 PM - Zacks.com


Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape
10/14/2014 9:04:00 AM - Zacks.com


Tekmira's Partner Announces Positive Clinical Data For LNP-Enabled Patisiran
10/14/2014 1:40:00 AM - RTT News


U.S. Stocks Fluctuate; Shutterfly Shares Decline On Aborted Merger Talks
10/13/2014 3:18:47 PM - Benzinga


Why Alnylam Pharmaceuticals Surged Higher
10/13/2014 1:26:54 PM - Motley Fool


Lithia Motors Dips On Lowered Earnings Forecast; CSX Shares Gain
10/13/2014 12:30:07 PM - Benzinga


Markets Down; Targa To Acquire Atlas Pipeline, Atlas Energy
10/13/2014 11:05:41 AM - Benzinga


Alnylam Pharmaceuticals Inc. (ALNY) Is Up Sharply On Study Results
10/13/2014 9:33:00 AM - RTT News


Alnylam Announces Data From Patisiran Phase 2 OLE Study In Patients With FAP
10/13/2014 6:10:00 AM - RTT News


Alnylam Begins New Study on Hepatic Porphyrias Patients - Analyst Blog
10/6/2014 6:40:00 PM - Zacks.com


Action in Ebola-Related Stocks
10/1/2014 9:15:00 AM - Fox Business


Alnylam Starts New Study on Cardiac Amyloidosis Patients - Analyst Blog
9/26/2014 5:10:00 PM - Zacks.com


Alnylam Pharma To Present At Biotech Industry Conference; Webcast At 1:30 PM ET
9/26/2014 12:30:00 PM - RTT News


Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
9/18/2014 5:10:00 PM - Zacks.com


Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
9/15/2014 7:00:00 PM - Zacks.com


Tekmira: Much More Than An Ebola Treatment
9/14/2014 7:57:00 PM - Seeking Alpha


Alnylam Pharm. To Present At Morgan Stanley Conference; Webcast At 10:20 AM ET
9/10/2014 9:20:00 AM - RTT News


ALNY Makes Notable Cross Below Critical Moving Average
9/5/2014 11:50:08 AM - BNK Invest


Gilead: Let's Make A Deal
8/28/2014 8:45:00 AM - Seeking Alpha


Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY
8/13/2014 4:35:29 PM - BNK Invest


Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus - Analyst Blog
8/11/2014 12:40:00 PM - Zacks.com


Alnylam Pharmaceuticals Has Plenty On Its Plate
8/9/2014 10:36:00 AM - Seeking Alpha